Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alibaba
BABA
|
+$422M |
| 2 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$411M |
| 3 |
iShares China Large-Cap ETF
FXI
|
+$351M |
| 4 |
Pfizer
PFE
|
+$331M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$319M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$4.28B |
| 2 |
Meta Platforms (Facebook)
META
|
+$989M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$953M |
| 4 |
Amazon
AMZN
|
+$816M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$782M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.06% |
| 2 | Consumer Discretionary | 1.41% |
| 3 | Healthcare | 0.83% |
| 4 | Financials | 0.79% |
| 5 | Industrials | 0.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
11826
PUT
Smartbird Inc
BIRD
$28.1M
| $29.6K | ﹤0.01% |
1,205
-125
| -9% | -$2.47K |
|
11827
CALL
InflaRx
IFRX
$360M
| $29.5K | ﹤0.01% |
18,100
-43,700
| -71% | -$74.9K |
|
|
CARM
11828
DELISTED
Carisma Therapeutics
CARM
| $29.5K | ﹤0.01% |
+10,062
| New | +$29.9K |
|
11829
Avalon Holdings
AWX
$10.5M
| $29.4K | ﹤0.01% |
12,293
-12,988
| -51% | -$26.6K |
|
11830
Atlantic American Corp
AAME
$27.3M
| $29.3K | ﹤0.01% |
12,299
-10,669
| -46% | -$20.1K |
|
|
USAS
11831
Americas Gold and Silver
USAS
$1.88B
| $29.3K | ﹤0.01% |
+46,093
| New | +$31.7K |
|
11832
CALL
Satellogic
SATL
$793M
| $29.1K | ﹤0.01% |
+16,600
| New | +$20.4K |
|
11833
Biodesix
BDSX
$317M
| $29K | ﹤0.01% |
+787
| New | +$24.7K |
|
11834
PUT
System1
SST
$16.9M
| $28.4K | ﹤0.01% |
+1,280
| New | +$18.9K |
|
11835
One Stop Systems
OSS
$274M
| $28.3K | ﹤0.01% |
13,482
-3,530
| -21% | -$7.1K |
|
|
11836
System1
SST
$16.9M
| $28.3K | ﹤0.01% |
1,274
-934
| -42% | -$13.8K |
|
|
LDTC
11837
DELISTED
LeddarTech
LDTC
| $28K | ﹤0.01% |
+10,916
| New | +$53.1K |
|
|
ORGN
11838
PUT
DELISTED
Origin Materials
ORGN
| $27.8K | ﹤0.01% |
1,103
+290
| +36% | +$8.31K |
|
|
11839
InflaRx
IFRX
$360M
| $27.7K | ﹤0.01% |
16,966
-20,125
| -54% | -$34.5K |
|
11840
ProQR Therapeutics
PRQR
$326M
| $27.7K | ﹤0.01% |
13,967
-26,643
| -66% | -$40.9K |
|
|
ADIL
11841
Adial Pharmaceuticals
ADIL
$15.2M
| $27.5K | ﹤0.01% |
+592
| New | +$32.4K |
|
11842
Deswell Industries
DSWL
$49.6M
| $27.3K | ﹤0.01% |
10,347
-15,386
| -60% | -$37.9K |
|
11843
Rallybio
RLYB
$89M
| $27.3K | ﹤0.01% |
+1,427
| New | +$34.9K |
|
11844
Vertical Aerospace
EVTL
$129M
| $27.3K | ﹤0.01% |
3,962
-2,836
| -42% | -$25.1K |
|
|
CEI
11845
PUT
DELISTED
Camber Energy, Inc
CEI
| $27.1K | ﹤0.01% |
118,000
-2,400
| -2% | -$717 |
|
|
DMK
11846
CALL
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
| $27K | ﹤0.01% |
38,600
| – | – |
|
|
KRON
11847
CALL
DELISTED
Kronos Bio
KRON
| $27K | ﹤0.01% |
21,600
+1,400
| +7% | +$1.55K |
|
|
TSP
11848
PUT
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $26.9K | ﹤0.01% |
30,600
-32,300
| -51% | -$33K |
|
|
ECDA
11849
DELISTED
ECD Automotive Design
ECDA
| $26.9K | ﹤0.01% |
+109
| New | +$166K |
|
|
OLOX
11850
Olenox Industries
OLOX
$2.49M
| $26.8K | ﹤0.01% |
4
-6
| -60% | -$38.4K |
|
Similar funds
Jeff Yass's Q4 2023 Portfolio in Review
As of Q4 2023, Jeff Yass held 13,823 positions worth $525B, up 9.3% from $481B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jeff Yass's Q4 2023 filing shows 1,903 new, 5,066 increased, 5,122 reduced and 1,577 closed positions. Its largest new stake was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $4.28B.
By sector, the portfolio is most concentrated in Technology at 2.1% of assets, down from 2.4% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- Jeff Yass's largest Q4 2023 buy was Vanguard Emerging Markets Government Bond ETF: 471,007 shares worth $30M.
- Jeff Yass added most to Alibaba in Q4 2023, an estimated $422M increase.
- Jeff Yass's biggest Q4 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $4.28B.
- Jeff Yass fully exited VMware, Inc in Q4 2023, selling an estimated $313M.
- Jeff Yass's ten largest holdings make up 24% of its $525B portfolio in Q4 2023.
- Jeff Yass opened 1,903 new positions and closed 1,577 in Q4 2023.
- Jeff Yass's portfolio value rose 9.3% quarter-over-quarter to $525B.
Based on Susquehanna International Group's 13F filing for Q4 2023, filed 14 Feb 2024.